Assessing the Capability of Cardiogoniometry (CGM) to Detect Changes in Cardiac Resynchronisation Therapy Device Settings (HF-CGM)
Heart Failure
About this trial
This is an interventional diagnostic trial for Heart Failure focused on measuring cardiac resynchronisation therapy, cardiogoniometry
Eligibility Criteria
Inclusion Criteria:
- Patients attending follow up clinic with a CRT device implanted.
- Patients have to be receiving CRT therapy - in other words, the device has to be functioning correctly.
- Aged 18 or over.
- The patient has been informed of the nature of the study and has provided full written informed consent.
Exclusion Criteria:
- Patients unable to give informed consent including those with communication difficulties due to poor English.
Sites / Locations
- Castle Hill Hospital
Arms of the Study
Arm 1
Experimental
Cardiogoniometry (CGM)
All patients attending clinic for follow up appointments following the implantation of a CRT device will be eligible for inclusion in the study. If they consent for enrolment in the study each patient will undergo a series of 4 CGM recordings whilst in their follow up appointment. They will undergo each of these during different pacemaker settings. These are: 1) No pacing, 2) Paced from the right ventricular lead; 3) Paced from the left ventricular lead and 4) Paced from both ventricular leads. After this has been done the participants involvement in the study will have finished.